Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Signaling through the high-affinity receptor for immunoglobulin E (Fc epsilon RI) results in the coordinated activation of tyrosine kinases, thus leading to calcium mobilization, degranulation, and leukotriene and cytokine synthesis. Here, we show that
CD84
, a member of the CD150 family of leukocyte receptors, inhibits Fc epsilon RI-mediated
mast cell
degranulation in
CD84
-transfected rat basophilic leukaemia-2H3
mast cell
line cells (RBL-2H3) through homophilic interaction. There was no reduction in overall protein phosphorylation following IgE triggering in
CD84
RBL-2H3 cells. Indeed, phosphorylation of Dok-1 and c-Cbl increased in
CD84
RBL-2H3, suggesting that inhibition is mediated by these molecules. MAP kinase phosphorylation (ERK1/2, JNK and p38) and cytokine synthesis were impaired in
CD84
RBL-2H3. This inhibitory mechanism was independent of SAP and SHP-2 recruitment. Interestingly,
CD84
mutants in tyrosines (Y279F and DeltaY324) reversed this inhibitory profile. These data suggest that
CD84
may play a role in modulating Fc epsilon RI-mediated signaling in mast cells. Thus,
CD84
could play a protective role against undesired allergic and inflammatory responses.
...
PMID:The leukocyte receptor CD84 inhibits Fc epsilon RI-mediated signaling through homophilic interaction in transfected RBL-2H3 cells. 1824 21